“METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN BY RP-HPLC” (2022) Journal of Pharmaceutical Negative Results, pp. 4316–4335. doi:10.47750/pnr.2022.13.S06.571.